Volpara Health Technologies Limited Financials

Market Capitalization A$282.9 Million as of Jan. 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE	-30.61
Forward PE	-114.00
Price to Sales TTM	A$7.65
Price to Book MRQ	A$6.06
Enterprise to Revenue	7.36
Enterprise to EBITDA	-35.38

Financial Reports as of Mar. 31, 2023

Financials

Fiscal Year Ends	2023-03-31
Most Recent Quarter	2023-03-31
Profit Margin	-23.50%
Operating Margin	-24.28%
Return on Assets TTM	-7.72%
Return on Equity TTM	-17.33%

Income Statement

Revenue TTM	A$34,524,691
Revenue per Share TTM	A$0.15
Quarterly Revenue Growth	17.50%
Gross Profit TTM	A$30,297,669
EBITDA	A$-7,181,768
Net Income to Common TTM	A$-8,114,843
Diluted EPS TTM	A$-0.04
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	A$11,995,381
Total Cash per Share MRQ	A$0.05
Total Debt MRQ	A$
Total Debt to Equity MRQ	2.78
Current Ratio MRQ	0.88
Book Value per Share MRQ	A$0.19

Cash Flow

Operating Cash Flow TTM	A$3,132,076
Levered Free Cash Flow TTM	A$5,565,484

VHT Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	254,828,992
Float Shares	191,411,579
Avg 10 Volume	1,043,767
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	25.03%
% Held by Institutions	20.32%

Stock Price Summary

Beta	1.68
Fifty Two Week Low	A$0.63
Fifty Two Week High	A$1.15
Fifty Two Week Change	35.81%
Day 50 MA	A$1.13
Day 200 MA	A$0.93

Dividends and Splits

Forward Annual Dividend Rate	A$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	A$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date